Biotech

36 articles in this category (Page 2 of 2)

Stock Weather AIBiotechMomentum Stocks

Regencell Bioscience – 2025-12-04 - Increase Confidence 6/10

Negative free cash flow and unprofitability clash with explosive momentum and recent 23% price surge, signaling speculative upside in the near term.

Dec 4, 2025RGC

Stock Weather AIBiotechAnalyst Revisions

Beam Therapeutics – 2025-12-03 - Increase Confidence 7/10

Narrowed loss beats estimates and FDA Regenerative Medicine designation for BEAM-101 signal near-term upside, supported by strong analyst momentum.

Dec 3, 2025BEAM

Stock Weather AIHealthcareBiotech

BillionToOne – 2025-12-02 - increase Confidence 7/10

Improving loss trajectory and strong analyst sentiment ahead of earnings suggest near-term upside for BillionToOne.

Dec 2, 2025BLLN

Stock Weather AIBiotechClinical Trials

Vera Therapeutics (VERA) – 2025-11-28 - Increase Confidence 6/10

Negative free cash flow and high debt weigh on fundamentals, but recent 8% price surge on positive trial sentiment signals near-term momentum for VERA.

Nov 28, 2025VERA

Stock Weather AIBiotechClinical Catalysts

Arrowhead Pharmaceuticals – 2025-11-27 - Increase Confidence 7/10

Strong free cash flow and deep pipeline momentum signal upside, with near-term Phase 3 readouts acting as catalysts for stock re-rating.

Nov 27, 2025ARWR

Stock Weather AIBiotechClinical Catalysts

Arcellx – 2025-11-25 - increase Confidence 6/10

Despite deteriorating revenue trends, upcoming clinical data readout and strong cash runway provide near-term catalysts for stock appreciation.

Nov 25, 2025ACLX

Stock Weather AIBiotechSpeculative Growth

Regencell Bioscience Holdings – 2025-11-25 - increase Confidence 7/10

Negative free cash flow and high debt/equity clash with AI/nuclear narrative and hedge fund interest, fueling speculative upside in the near term.

Nov 25, 2025RGC

Stock Weather AIBiotechRegulatory Catalysts

Scholar Rock – 2025-11-18 - Increase Confidence 8/10

Negative free cash flow offset by strong cash runway and recent FDA progress on apitegromab; regulatory catalysts likely to drive near-term upside.

Nov 18, 2025SRRK

Stock Weather AIBiotechClinical-Stage Pharma

Terns Pharmaceuticals – 2025-11-18 - Increase Confidence 7/10

Negative free cash flow offset by strong cash runway and imminent TERN-701 data catalyst in December → near-term upside likely.

Nov 18, 2025TERN

Stock Weather AIBiotechClinical Trials

Jyong Biotech – 2025-11-17 - increase Confidence 7/10

Negative free cash flow contrasts with imminent Phase II trial data readout for MCS-8, a catalyst likely to drive near-term upside.

Nov 17, 2025MENS

Stock Weather AIBiotechM&A

Avadel Pharmaceuticals – 2025-11-14 - Increase Confidence 8/10

Positive cash infusion and M&A interest override negative cash flow as LUMRYZ legal win fuels near-term upside.

Nov 14, 2025AVDL

Stock Weather AIBiotechClinical Catalyst

Cidara Therapeutics – 2025-11-14 - Increase Confidence 7/10

Negative free cash flow contrasts with strong analyst consensus and recent clinical trial progress, signaling near-term upside on potential partnership or data readout.

Nov 14, 2025CDTX